Moderna Rallies 8% on 2026 Melt-Up Momentum Even While BioNTech and Merck Stay Flat

Moderna (NASDAQ:MRNA | MRNA Price Prediction) stock is up 8% to $147.37 in Friday morning trading, a sharp single-name move on a session when biotech as a group is quiet and broader U.S. equities are only modestly higher.